Literature DB >> 11518629

FK506 facilitates chemical kindling induced by pentylenetetrazole in rats.

K Suzuki1, S Omura, Y Ohashi, M Kawai, Y Iwata, K Tani, Y Sekine, N Takei, N Mori.   

Abstract

To clarify the possible role played by calcineurin in kindling development, we examined the effects of pretreatment with FK506, a selective calcineurin inhibitor, on pentylenetetrazole (PTZ) kindling in rats. FK506 facilitated the speed of kindling induced by repeated administration of 30-mg/kg PTZ, while FK506 did not ameliorate acute seizure manifestations after a single injection of PTZ. Our results suggested that calcineurin might exert an inhibitory effect on PTZ kindling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518629     DOI: 10.1016/s0920-1211(01)00284-4

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  6 in total

Review 1.  Targeting inflammation as a therapeutic strategy for drug-resistant epilepsies: an update of new immune-modulating approaches.

Authors:  Giovanna Vitaliti; Piero Pavone; Fahad Mahmood; Giuseppe Nunnari; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2014-03-07       Impact factor: 3.452

2.  Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats.

Authors:  Xinyue Jing; Xiang Liu; Tao Wen; Shanshan Xie; Dan Yao; Xiaodong Liu; Guangji Wang; Lin Xie
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

Review 3.  Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants.

Authors:  Germán Sierra-Paredes; Germán Sierra-Marcuño
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

4.  The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus.

Authors:  Carmen Freire-Cobo; Germán Sierra-Paredes; Manuel Freire; Germán Sierra-Marcuño
Journal:  J Neuroimmune Pharmacol       Date:  2014-08-08       Impact factor: 4.147

Review 5.  Neuroinflammation: A Signature or a Cause of Epilepsy?

Authors:  Enrico Pracucci; Vinoshene Pillai; Didi Lamers; Riccardo Parra; Silvia Landi
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

6.  Modulation of Immunity and the Inflammatory Response: A New Target for Treating Drug-resistant Epilepsy.

Authors:  Nian Yu; Hao Liu; Qing Di
Journal:  Curr Neuropharmacol       Date:  2013-01       Impact factor: 7.363

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.